From day one, we have been passionate about leveraging our expertise in the high-tech ceramics industry to create new, innovative opportunities in multiple sectors. To this end, our company has a state of the art manufacturing facility and headquarters in Salt Lake City.
We are also publicly traded on the NASDAQ (SINT) and operate an FDA registered, ANVISA registered, and ISO 13485 certified manufacturing facility.
We have poured a tremendous amount of resources into the research and development of our hallmark, silicon nitride (Si3N4) material. We have leveraged the capability of this unique material to improve the quality of life of people all over the world as well as expand our interests into multiple industries, while broadening our vision.
It all started with silicon nitride and its capacity to change the biomedical field. Clinical studies performed in animal and in-vitro studies demonstrated that a silicon nitride ceramic implant outperformed its competitors such as PEEK and titanium. This material is stable over the long-term, shows up on imaging easily, has superior strength, and is a versatile material in the medical setting.
These powerful antibiotic and healing properties contributed to the rapid growth of SINTX technologies and Si3N4. During this time, silicon nitride has proven effective in more than 35,000 spinal fusion implants leading to the award of more than 60 patents.Learn More
Now, our high-tech ceramics R&D departments have expanded our company’s investments to include transportation, aerospace, and defense. At SINTX, we are exploring new approaches to industrial applications. This includes the development of novel materials with a focus on high-end applications.
Our materials have proven effective with superior temperature and thermal shock tolerance along with a strong resistance against fracture, oxidation, and general wear and tear. Therefore, our materials are suitable for areas such as: